It’s hard to know how many lives were lost over the irrational fear being pushed by the left and their allies in the media about the lie that hydroxychloroquine is a dangerous drug that doesn’t help COVID19 patients.
The Association of American Physicians and Surgeons has filed a lawsuit against the Department of Health & Human Services & FDA for “irrational interference by the FDA with timely access to hydroxychloroquine.”
Yesterday evening, Dr. Ned Nikolov tweeted a copy of the lawsuit.
The lawsuit reads:
AAPS brings this action on behalf of its members and their patients to end the irrational interference by the FDA with timely access to hydroxychloroquine (“HCQ”), which has been donated in large quantities to the federal government for prompt distribution. Specifically, AAPS seeks an injunction against the FDA’s Emergency Use Authorization dated March 28, 2020 (“EUA”), which prohibits use of the donated HCQ except for already-hospitalized patients for whom clinical trials are unavailable.
2. Through a biased, unlawful process described in greater detail below, FDA officials from prior administrations acted contrary to the wishes of President Donald Trump, by arbitrarily limiting use of HCQ from the Strategic National Stockpile (SNS) “to prescribe to adolescent and adult patients hospitalized with COVID-19, as appropriate, when a clinical trial is not available or feasible.”1
3. Specifically, a Barack Obama-appointed official who is outspokenly critical of President Trump, Rick Bright, personally opposed making HCQ widely available to the public from the federal SNS, and distorted the agency process to arbitrarily and unjustifiably limit access by patients to HCQ received as donations by the federal government for the purpose of making it available promptly to the public.
4. HCQ has been approved as safe by the FDA for sixty-five(65) years and is safer than numerous medications that are widely available over the counter (“OTC”) without requiring a prescription, including anti-depressants (St John’s Wort), sleeping pills (diphenhydramine), bronchodilators (ephedrine), many pain medications including ibuprofen, acetaminophen (Tylenol®), and even aspirin. HCQ is not addictive in any way.
5. President Donald Trump himself has repeatedly praised HCQ, and he announced on May 18, 2020 that on his own initiative and with his physician’s advice and prescription, Trump took a full regimen of HCQ himself as a prophylaxis against COVID-19, as other world leaders have reportedly been doing.
6. The arbitrary, irrational, and unjustifiable interference by Defendants with the use of HCQ as a prophylaxis interferes with the political process by which the United States selects its president: national political conventions. For nearly two centuries, thousands of delegates attend a national political convention together to nominate their candidate for president and to present their slate to the American public. Continued, irrational interference by Defendants with a safe prophylaxis for COVID-19 has the effect of infringing on the right of the people to hold national political conventions, which have been an essential part of our presidential elections since at least 1832.
7. Efforts to persuade the FDA to remove its irrational limitations of hospitalization and non-availability of a clinical trial have been unsuccessful and petitioning the FDA amid the conflicts of interests among its officials would be futile on this issue.
8. These arbitrary, irrational, and unjustifiable limitations by the FDA in its EUA prevents the use of HCQ as a prophylaxis in nursing homes and when in the best interests of non- hospitalized patients.
9. HCQ, like most medications, loses its efficacy over time, particularly at warmer temperatures which are occurring now as summer approaches. Most of the HCQ doses in the SNS will be discarded for their loss in efficacy if the FDA restrictions on its use are not promptly lifted.
10. There will be irreparable, immediate harm to AAPS members and their patients if the arbitrary, irrational, and unjustifiable restrictions by FDA on use of HCQ from the SNS are not enjoined and declared invalid immediately.
Why is an effective & inexpensive drug treatment of #COVID19 being suppressed by FDA?
There is one plausible answer: the successful treatment of COVID19 patients with hydroxychloroquine threatens the sale of billions of doses of a COVID19 vaccine to the World later on…😎
— Ned Nikolov, Ph.D. (@NikolovScience) June 14, 2020
In a follow-up tweet, Dr. Nikolov suggests that the reason the “effective and inexpensive drug treatment of COVID19 is being suppressed by the FDA is that it threatens the sale of billions of doses of a COVID19 vaccine.
The Gateway Pundit reports – Never in history have we seen such a determined effort by the scientific community and pharmaceutical industry to downplay and lie about the use of a successful drug to treat a deadly disease.
Hydroxychloroquine is the first choice in a study of 6,000 doctors treating the coronavirus.
In the field and in independent testing hydroxychloroquine displayed amazing results in treating the COVID-19 virus.
But there was great pushback against hydroxychloroquine for two reasons. The first reason was that it was safe and very inexpensive. The second reason is that Donald Trump promoted its use.
On June 5th, it was discovered that the Lancet Study on Hydroxychloroquine was a complete fraud after they apologized for publishing a fraudulent study that was used to justify the media’s attacks on Trump for promoting the benefits of the inexpensive drug for coronavirus victims.
Reuters – An influential study that found hydroxychloroquine increased the risk of death in COVID-19 patients has been withdrawn a week after it led to major trials being halted, adding to the confusion about a malaria drug championed by U.S. President Donald Trump.
The Lancet medical journal pulled the study after three of its authors retracted it, citing concerns about the quality and veracity of data in it. The World Health Organization (WHO) will resume its hydroxychloroquine trials after pausing them in the wake of the study. Dozens of other trials have resumed or are in process.
The three authors said Surgisphere, the company that provided the data, would not transfer the dataset for an independent review and they “can no longer vouch for the veracity of the primary data sources.”
The Gateway Pundit reported about the co-authors of the sham study and reports that they are linked to the pharmaceutical industry.
Sapan Desai, the CEO of Surgisphere and his co-authors made up the figures in the report. None of the data was based on hospital records. They have essentially forged the numbers in the report and got published in major scientific journals like the Lancet without any peer review.
Surgishphere the company that published the paper is made up of two employees, Sapan Desai (the CEO) and his wife, Nikki Desai who is listed as the director of the company.
The funding source for the paper was a major US-based pharmaceutical.